Large-scale testing (Phase 3)Study completedNCT02504216
What this trial is testing
Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities
Who this might be right for
Peripheral Artery Disease
Bayer 6,564